AzTrials
AzTrials

Parkinson DiseaseNCT05529121

Developing Personalized Medicine Strategies to Increase Physical Activity in Parkinson's Disease (PD) Through Digital Health Technology

An observational study of Parkinson Disease, run by Corporal Michael J. Crescenz VA Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Under a grant from the Department of Defense's PD program, Dr. Morley's is investigating new approaches that 1) use "gamification"- applying rules of games like point scoring, achieving silver, gold or platinum levels and competition-- to increase physical activity in PD; 2) identify whether certain PD patient respond… Read more about this study

Who is it for?
Ages 40 to 89 yearsHealthy volunteers can take part
Conditions the study is for
Parkinson Disease
How many people
88 participants
Where
1 siteUnited States
Study dates
3 Dec 2021to 1 Jul 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 89 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Veteran participants within the VISN4 region (a network of 9 VA medical centers and 45 outpatient clinics, covering Pennsylvania, Delaware and parts of Ohio, West Virginia, New York and New Jersey).

Who may be able to join

None listed.

Who cannot join

  • Diagnosis of an atypical parkinsonian syndrome or concomitant administration of a drug that could cause parkinsonian syndromes.
  • Cardiovascular or other medical comorbidities that preclude participation in an intervention to increase physical activity
  • Lack of access to a smartphone or other device (tablet or networked computer) that can be used to interface with the Fitbit app and Way to Health platform
  • PD Hoehn/Yahr stage >2.5 indicating significant balance or functional impairment that would preclude participation in an intervention to increase physical activity
  • Clinical diagnosis of dementia
  • Active impulse control disorder

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Corporal Michael J. Crescenz VA Medical Center

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

Under a grant from the Department of Defense's PD program, Dr. Morley's is investigating new approaches that 1) use "gamification"- applying rules of games like point scoring, achieving silver, gold or platinum levels and competition-- to increase physical activity in PD; 2) identify whether certain PD patient respond differently to gamification interventions than others.; 3) use readily and commercially available (including Fitbits) digital health technologies to perform all study activities remotely and enable a "touchless" study where patients don't have to come in person for any studies visits. The study is underway and actively recruiting.

Read the detailed description

Objectives(s): To investigate whether: 1) Protocols using gamification to increase physical activity in patients with PD employing remote intervention and assessment will be feasible and acceptable to participants; 2) Individual NMS will predict responsiveness to a gamification intervention targeting physical activity levels-facilitating a personalized approach in future efficacy studies; 3) Changes in physical activity will be associated with changes in motor symptoms, measured using the wearable Parkinson's Kinetograph (PKG)

Research Design: This is a prospective observational study. Using administrative databases and review of medical records, we will identify and remotely enroll 85 Veterans with PD on stable medication regimens into a protocol including: 1) Two week assessment of baseline activity using Fitbits; 2) a 6-week gamification intervention program targeted to a 20% increase in average daily steps; 3) 4-week follow-up period after the intervention. At baseline and following the gamification period, we will assess a variety of NMS in PD using validated questionnaires. PD motor symptoms will be assessed using the PKG (bradykinesia and motor scores) at baseline, at the end of the gamification program and after follow-up..

Methodology: All survey assessments, activity monitoring and administration of the gamification intervention will be conducted remotely using Way to Health, a web-based digital health platform developed at the University of Pennsylvania. Participants will complete surveys at the beginning of the study that quantify various sociodemographic, clinical, and geographical factors using the Way to Health platform. All participants will be mailed a Fitbit Inspire, a wearable activity tracker to be worn on the hip for 30 days to record daily steps. Participatiants will also be mailed a Parkinson's Kinetograph (PKG) to wear at baseline, at the end of the gamification program and after follow-up. Participants will sync their Fitbit data to the Way to Health platform, that has been used for previous clinical trials at the CMCVAMC. Statistical analysis: Aim 1: We will assess feasibility of the intervention using descriptive statistics; Aim 2: We will examine the association of baseline disease characteristics with response to the intervention using linear mixed effects models Aim 3: We will examine the association between changes in physical activity and motor symptoms using linear mixed effects models.

Clinical relationships: Exercise and physical activity are potential "silver bullets" in the treatment of Parkinson's disease (PD). Exercise has efficacy as a symptomatic and potentially disease-modifying therapy. However, low levels of physical activity in community-dwelling populations with PD demonstrate that exercise is not yet being used as an effective therapy. Interventions to increase activity levels of PD patients under real world conditions will have tremendous and immediate translational impact. Personalized strategies using digital health technology to increase physical activity would be highly scalable, improving the symptoms and lives of countless people living with PD The COVID19 pandemic halted most human-subjects research because of the need for face to face recruitment and visits. Traditional models of face to face recruitment and assessment are unlikely to be viable during the funding period for the proposed studies, and, perhaps, beyond. Approaches to recruitment and assessment that circumvent the need for face to face contact will have high impact.

Impact/Significance: Personalized strategies using digital health technology to increase physical activity would be highly scalable, improving the symptoms and lives of countless people living with PD.

Keywords
Parkinson's Disease, Exercise, Economics, Behavioral
Medical subject headings
Parkinson Disease, Motor Activity, Behavior

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Determine the feasibility and acceptability of a "touchless" intervention to increase physical activity in patients with PD using digital health technology and behavioral economics strategies

    Protocols using gamification to increase physical activity in patients with PD employing remote intervention and assessment will be feasible and acceptable to participants. Specifically we hypothesize that subjects will: H1a) wear their activity monitor ≥ 80% of the time; H1b) successfully create a remote monitoring account and sync their device; H1c) wear and capture motor symptoms with the PKG and H1d) report high program acceptability (Intrinsic Motivation Inventory score ≥ 5)

    Measured: 2026

  2. Determine whether non-motor features predict responsiveness to a behavioral economic-based gamification intervention to increase physical activity in patients with PD

    Non-motor and features, in particular risk aversion as measured by the DOSPERT scale, will be associated with change in daily step count during the gamification intervention

    Measured: 2026

  3. Determine whether changes in physical activity in response to a gamification intervention impact PD motor symptoms measured using a remotely-monitored wearable device

    Increased activity during the gamification intervention will be associated with improvement of motor scores remotely measured using the Parkinson's Kineticgraph (PKG)

    Measured: 2026

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Sep 2022
  2. Study start3 Dec 2021
  3. Primary completion1 Jul 2024
  4. Study completion1 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
88 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05529121
Sponsor's protocol ID
1616612
Status last verified
Jul 2024
First submitted
1 Sep 2022
Last updated
29 Jul 2024
Results posted
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Parkinson Disease, run by Corporal Michael J. Crescenz VA Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Determine the feasibility and acceptability of a "touchless" intervention to increase physical activity in patients with PD using digital health technology and behavioral economics strategies (time frame: 2026). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in